UČESTALOST NUSPOJAVA in English translation

• frequency of adverse reactions
• frequency of side effects
• incidence of adverse reactions
• frequencies of adverse reactions
• incidence of side effects

Examples of using Učestalost nuspojava in Croatian and their translations into English

Učestalost nuspojava prikazana je na sljedeći način: Vrlo često ≥ 1/10.
Adverse reaction frequencies are reported as: Very common≥ 1/10.

Učestalost nuspojava u odraslih bolesnika koji su sudjelovali u kliničkim ispitivanjima Eurartesima.
Frequency of ADRs in adult patients participating in clinical studies with Eurartesim.

U cjelini, učestalost nuspojava povećala se neznatno.
Overall, the frequency of adverse reactions increased slightly.

Učestalost nuspojava povećavala se s dozom.
The frequency of adverse reactions increased with dose.

Učestalost nuspojava definira se prema sljedećem pravilu.
The frequency of adverse reactions is defined using the following convention.

Učestalost nuspojava definirana je kako slijedi.
The frequency of adverse reactions is defined using the following convention.

Učestalost nuspojava određena je sukladno sljedećim pravilima.
The frequency of adverse reactions is defined using the following convention.

Učestalost nuspojava prema dozi bila je sljedeća.
The per-dose frequency of adverse reactions was as follows.

Učestalost nuspojava povezanih s INCIVOM navedena je u daljnjem tekstu.
The frequency rate of the side effects associated with INCIVO is given below.

Tablica 1: Učestalost nuspojava utvrđenih iz placebom kontroliranih kliničkih ispitivanja samih sitagliptina
Table 1: The frequency of adverse reactions identified from placebo-controlled clinical studies of sitagliptin and metformin alone,

Tablica 1 Učestalost nuspojava prema klasifikaciji organskih sustava iz kliničkih ispitivanja
Table 1 Frequency of adverse reactions by system organ class from clinical trials

Učestalost nuspojava je bila niža u grupi djece koja su primila polovicu doze za odrasle.
The frequency of side effects was lower in the group of children who received half of the adult dose.

Tablica 1 Učestalost nuspojava prema klasifikaciji organskih sustava u udruženim usporednim kliničkim ispitivanjima faze 3.
Table 1 Frequency of adverse reactions by System Organ Class in pooled Phase 3 comparative clinical studies.

Učestalost nuspojava nakon stavljanja orlistata u promet nije poznata jer su nuspojave prijavljivane dragovoljno, a veličina populacije nije poznata.
The frequencies of adverse reactions identified during post-marketing use of orlistat are not known as these reactions were reported voluntarily from a population of uncertain size.

Tablica 1: Učestalost nuspojava Bronchitola tijekom faze liječenja
Table 1: Frequency of adverse reactions with Bronchitol during the treatment phase

U donjoj tablici prikazana je učestalost nuspojava prijavljenih kliničkim istraživanjima
The table below shows the frequencies of adverse reactions which have been reported in clinical trials

Tablica 5 Učestalost nuspojava prema organskim sustavima na temelju kliničkih ispitivanja
Table 5 Frequency of adverse reactions by system organ class from clinical trials

Učestalost nuspojava utvrđenih iz placebom kontroliranih kliničkih ispitivanja samih sitagliptina
The frequency of adverse reactions identified from placebo-controlled clinical studies of sitagliptin and metformin alone,

Učestalost nuspojava utvrđenih iz placebom kontroliranih kliničkih ispitivanja sitagliptina
The frequency of adverse reactions identified from placebo-controlled clinical studies of sitagliptin monotherapy

Učestalost nuspojava zabilježenih nakon stavljanja lijeka u promet ne može se odrediti jer su izvedene iz spontanih prijava.
The frequency of adverse reactions reported during post-marketing use cannot be determined as they are derived from spontaneous reports.